Reuters logo
BRIEF-Adverum Biotechnologies Q4 loss per share $0.54
March 6, 2017 / 2:32 PM / 7 months ago

BRIEF-Adverum Biotechnologies Q4 loss per share $0.54

March 6 (Reuters) - Adverum Biotechnologies Inc:

* Adverum Biotechnologies reports fourth quarter and full year 2016 financial results and provides update

* Q4 loss per share $0.54

* Q4 earnings per share view $-0.30 -- Thomson Reuters I/B/E/S

* Qtrly collaboration and license revenue $488,000 versus $960,000

* Adverum Biotechnologies Inc - for ADVM-043, co is planning to engage with FDA to review development plans under an open ind in first half of 2017

* Adverum Biotechnologies- cash and cash equivalents of $222.2 million as of Dec 31, 2016 expected to fund 3 lead gene therapy programs through end of 2019 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below